| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,100 |
2,403 |
$304K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,607 |
1,224 |
$188K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
608 |
462 |
$53K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
185 |
148 |
$24K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
308 |
211 |
$23K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
881 |
697 |
$21K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
645 |
498 |
$18K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
315 |
243 |
$7K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
409 |
323 |
$5K |
| 70450 |
Computed tomography, head or brain; without contrast material |
33 |
24 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
530 |
432 |
$2K |
| 80053 |
Comprehensive metabolic panel |
1,114 |
885 |
$2K |
| 85027 |
|
1,471 |
1,145 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
818 |
640 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
625 |
248 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
154 |
127 |
$968.99 |
| 87430 |
|
341 |
270 |
$809.82 |
| 83690 |
|
590 |
470 |
$686.20 |
| 84703 |
|
475 |
375 |
$666.90 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
826 |
636 |
$630.90 |
| 81001 |
|
879 |
689 |
$492.48 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
319 |
242 |
$484.68 |
| 81025 |
|
382 |
309 |
$457.92 |
| 87070 |
|
238 |
185 |
$411.60 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
116 |
90 |
$286.30 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,213 |
616 |
$215.84 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
17 |
13 |
$153.96 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12 |
12 |
$140.27 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
33 |
33 |
$123.69 |
| 84484 |
|
98 |
96 |
$107.36 |
| 83880 |
|
15 |
15 |
$69.48 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
129 |
101 |
$47.20 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
24 |
14 |
$36.80 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
433 |
342 |
$35.10 |
| 84702 |
|
15 |
13 |
$28.74 |
| 80076 |
|
26 |
13 |
$27.85 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$23.94 |
| J7050 |
Infusion, normal saline solution, 250 cc |
298 |
235 |
$23.72 |
| 81003 |
|
15 |
12 |
$16.83 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
28 |
24 |
$4.80 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
15 |
14 |
$0.17 |